Leon inks Series B

Leon, a German enabler of nano technology for the pharmaceutical industry, has secured Series B funding.

Leon, a German enabler of nano technology for the pharmaceutical industry, has secured Series B funding. No financial terms were disclosed. The investors included TVM Life Science Innovation I.L.P., CD-Venture GmbH, Albany Private Equity Holdings Pty Ltd, Eckenstein-Geigy-Stiftung, LOF Leon Partnership, L.P., Evotec SE and BayBG.

Source: Press Release